Form 10-Q Sana Biotechnology, Inc. For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Sana Biotechnology (SANA) PT Raised to $15 at Citi, Opens Positive Catalyst Watch
August 9, 2024 5:01 AM EDTCiti analyst Samantha Semenkow raised the price target on Sana Biotechnology (NASDAQ: SANA) to $15.00 (from $8.00) while maintaining a Buy rating.
The analyst comments "Sana disclosed they have enrolled multiple T1D patients into the IST being conducted in Uppsala, Sweden. The... More
